Systematic Review of Whole-Genome Sequencing Data To Predict Phenotypic Drug Resistance and Susceptibility in Swedish Mycobacterium tuberculosis Isolates, 2016 to 2018
Authors:
- 21 April 2020
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 64 (5)
Abstract
In this retrospective study, whole-genome sequencing (WGS) data generated on an Ion Torrent platform was used to predict phenotypic drug resistance profiles for first- and second-line drugs among Swedish clinical Mycobacterium tuberculosis isolates from 2016 to 2018. The accuracy was ∼99% for all first-line drugs and 100% for four second-line drugs. Our analysis supports the introduction of WGS into routine diagnostics, which might, at least in Sweden, replace phenotypic drug susceptibility testing in the future.Keywords
Funding Information
- Folkhälsomyndigheten
This publication has 6 references indexed in Scilit:
- Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosisClinical Microbiology and Infection, 2019
- Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA SequencingNew England Journal of Medicine, 2018
- Role of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosisJournal of Clinical Microbiology, 2018
- Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis toolsScientific Reports, 2017
- Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective studyThe Lancet Respiratory Medicine, 2016
- Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB MutationsJournal of Clinical Microbiology, 2013